Selected Safety Information

BLI, beta-lactamase inhibitor; CR, carbapenem-resistant; CRE, carbapenem-resistant Enterobacterales; KPC, Klebsiella pneumoniae carbapenemase; LTC, long-term care; P. aeruginosa, Pseudomonas aeruginosa

Reference:

1. Young K, Painter RE, Raghoobar SL, et al. In vitro studies evaluating the activity of imipenem in combination with
   relebactam against Pseudomonas aeruginosa. BMC Microbiol. 2019;19(1):150. doi:10.1186/s12866-019-1522-7
2. RECARBRIOTM SPC, Feb 2021

AE-TIX-00032 | Exp 15 Aug 2027